c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech
![Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam](https://www.abcam.com/ps/products/216/ab216574/Images/ab216574-480637-antimet-cmet-antibody-ep1454y--nterminal-western-blot.JPG "Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam")
Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam
AACR 2023: YH013, a Novel Bispecific EGFR x MET Antibody-Drug Conjugate, Exhibits Potent Anti-Tumor Efficacy - Biocytogen
Met Antibody | Cell Signaling Technology
They Should Be in Jail': Nan Goldin, Anti-Sackler Opioid Activists Take Fight to Guggenheim, Met – ARTnews.com
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
![Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)](https://www.abcam.com/ps/products/227/ab227637/Images/ab227637-290322-anti-met-c-met-antibody-sp44-c-terminal-immunohistochemistry.jpg "Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)")
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
Frontiers | The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
Met (c Met) Polyclonal Antibody – Bioss
Amivantamab (JNJ-61186372) is a Human EGFR-MET Bispecific Antibody - Network of Cancer Research
![Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)](https://www.abcam.com/ps/products/227/ab227637/Images/ab227637-4-AntiMet-cMet-antibody-SP44--Cterminal-IHC-Human-colon-carcinoma.jpg "Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)")
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM | PNAS
Met (c Met) Polyclonal Antibody – Bioss
![Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)](https://www.abcam.com/ps/products/51/ab51067/Images/ab51067-254008-anti-met-c-met-antibody-ep1454y-n-terminal-immunohistochemistry.jpg "Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)")
Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)
Anti-MET Antibody (PACO01060) | WB
Frontiers | The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth
JPM | Free Full-Text | MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer—A Review
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition | Journal of Nuclear Medicine
c-Met Monoclonal Antibody (3D4) (18-7366)
InlB-Dependent Internalization of Listeria Is Mediated by the Met Receptor Tyrosine Kinase: Cell
IJMS | Free Full-Text | Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain
7 Inhibition of MET signaling in cancer therapies. Anti-HGF monoclonal... | Download Scientific Diagram
Biomedicines | Free Full-Text | Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy
c-Met Polyclonal Antibody (PA5-85951)
Anti-c-Met antibody
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
